Embryoxite
Embryoxite is an innovative company redefining the future of in vitro fertilization (IVF) by developing an AI-powered technology platform that integrates clinical patient data, embryo metabolomic profiles, genetic information, and morphokinetic imaging to accurately predict embryo implantation potential. Their non-invasive metabolomics approach analyzes embryo metabolism through metabolites exchanged with the culture medium, providing vital implantation insights. By leveraging artificial intelligence, Embryoxite delivers predictive implantation scores that enhance decision-making in Assisted Reproduction Treatment (ART), increasing pregnancy success rates, reducing time and costs, and improving outcomes for patients. The company operates with a strong ethical commitment and scientific rigor, supported by a multidisciplinary team and recognized by innovation awards.
Embryoxite
Embryoxite is an innovative company redefining the future of in vitro fertilization (IVF) by developing an AI-powered technology platform that integrates clinical patient data, embryo metabolomic profiles, genetic information, and morphokinetic imaging to accurately predict embryo implantation potential. Their non-invasive metabolomics approach analyzes embryo metabolism through metabolites exchanged with the culture medium, providing vital implantation insights. By leveraging artificial intelligence, Embryoxite delivers predictive implantation scores that enhance decision-making in Assisted Reproduction Treatment (ART), increasing pregnancy success rates, reducing time and costs, and improving outcomes for patients. The company operates with a strong ethical commitment and scientific rigor, supported by a multidisciplinary team and recognized by innovation awards.